3rd Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

Advancing Cardiology Care Through Professional Education®

Saturday, September 28, 2019
The Westin New York at Times Square
270 West 43rd Street
New York NY, 10036

Overview

NEW YORK CARDIO-ENDO-RENAL COLLABORATIVE (NY CERC) focuses primarily on the strategic and novel approaches to management of integrated cardiometabolic diseases. This highly pragmatic and engaging conference blends in cutting-edge information delivered by expert academic physicians who, through a multitude of “challenging cases”, provide the latest clinical updates related to state-of-the-art treatment in patient care. This conference will offer you the opportunity to advance your understanding and knowledge of chronic cardiometabolic and associated comorbidities.

Target Audience

This educational activity is directed toward cardiologists, endocrinologists, specialty nurse practitioners, specialty physician assistants, certified diabetes educators, other specialty allied health professionals, nephrologists, and other health care professionals (HCPs).

Acknowledgment of Commercial Support

This activity is supported by educational grants from Akebia Therapeutics, Amarin, AstraZeneca, and Pfizer-Merck Alliance.

Accreditation/ Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 8.25 Contact Hours.

Learning Objectives

At the conclusion of this activity, the participant should be better prepared to:

  • Discuss clinical strategies for evaluation and diagnosis of patients presenting with cardiac, endocrine, and renal disease
  • Evaluate the rationale behind current and emerging testing used in the stratification of cardiometabolic risk in order to optimize the use of current and emerging agents or therapeutic strategies
  • Recognize and devise strategies to manage treatment-related adverse events and side effects in care of patients with cardiac, endocrine, and renal disease
  • Discern the potential clinical impact of recent clinical trial data on management of cardiac, endocrine, and renal disease
  • Identify current strategies and recent advancements in the prevention of cardiometabolic disorders
  • Assess barriers to care of patients with cardiac, endocrine, and renal disease
  • Employ strategies for patient counseling to improve education, preventative practices, adherence, and self-management

Program Co-Chairs


Stephen A. Brunton, MD, FAAFP
Executive Vice President for Education
Primary Care Education Consortium
Charlotte, NC
Adjunct Associate Clinical Professor
Department of Family Medicine
Touro University California Vallejo, CA


Keith C. Ferdinand, MD, FACC, FAHA, FASH, FNLA
Gerald S. Berenson Chair in Preventative Cardiology
Professor of Clinical Medicine
Tulane University Heart and Vascular Institute
New Orleans, LA


James A. Underberg, MD, MS, FACPM, FACP, FNLA, FASPC
Past President, National Lipid Association
Clinical Assistant Professor of Medicine
NYU Grossman School of Medicine
New York, NY